We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

Annual Bispecific Antibody Lisbon Summit

The Curtis & Wyss Group is pleased to invite you to the, Annual Bispecific antibody Lisbon summit, scheduled on March 23-24, 2017 in Lisbon, Portugal.

This premier B2B event will focussed completely on the development of bispecifics Antibody, the Annual Bispecific antibody Lisbon summit represents a unique opportunity to engage with your peers to discuss strategies to overcome the key challenges holding back progress in the field. 

Built using insights from experts, this year’s Bispecific Antibody Lisbon summit will incorporate more developmental and clinical insights than ever before. Rather than presenting vague overviews of platforms, this meeting will delve directly into the technical and scientific insights that will enable you to advance your candidate therapeutic into the clinic as efficiently and cost-effectively as possible. 


Key Practical Learning Points of the Summit: 

  • Optimize early decision makingto guarantee target synergy early in the development of multispecific therapeutics, with insights into Sanofi’s novel bispecific development programs
  • Validate bispecific formats in comparison with monoclonal approachesby learning from innovative analytical approaches, including Janssen’s dual binding and single target assays
  • Understand how Pfizer have enhanced bispecific IgG generation by bypassing the need for post purification recombination processes
  • Improve translatability into the clinic by investigating how Immunocore maximize the predictability of in vitro models
  • Investigate novel multispecific approaches for applications spanning beyond oncology, including in- depth case studies into innovative bispecific programs in autoimmune, neurodegenerative and infectious disease indications
  • Determine the characteristics required to ensure clinical success by examining key factors from clinical bispecific programs at Merrimack, Amgen and Macrogenics
  • Leave World Bispecific with clear insights that will dramatically improve the success of your bispecific development


WHY should you be there?

CEO, CSO, VP, Director, Head and Scientists in: 

  • Bispecifics
  • Antibody/Biologics
  • R&D
  • Therapeutic Areas
  • Discovery
  • Target ID & Validation
  • Process Development
  • Manufacturing/CMC
  • Bioanalysis
  • Clinical Development
  • Business Development


23 March 2017 @ 08:30 am

24 March 2017 @ 05:00 pm

Duration: 1 days, 8 hours




13000 Lisbon


Organised by

Curtis Wyss (view profile)

Similar Events in Biotechnology

Bulgarian Pharmaceutical Days 2017

Bulgaria, 23 June 2017

Similar Webinars in Biotechnology

Recent Publications in Biotechnology

The shape of the invisible

Publication, youris.com GEIE , February 2017

Meet the Atom

Publication, youris.com GEIE , February 2017

Recent Videos in Biotechnology


Biotechnology, 21 March 2017

European space solutions 2016 - The Hague

Biotechnology, 21 March 2017

Recent News in Biotechnology

Did you already read the March edition of our newsletter ? https://t.co/HpGIloA7xB Enjoy reading! https://t.co/IjIOXWun9R

@EU_ScienceHub - 25 March 2017 16:00

We are doing science for society since 60 years! Learn more: https://t.co/GqJ4THZmQw #EU60 #FutureOfEurope #JRC60… https://t.co/GCjjxr4bVo

@EU_ScienceHub - 25 March 2017 16:00

60 years of the EU in 60 seconds!

@EU_ScienceHub - 25 March 2017 15:00

ERC President Jean-Pierre Bourguignon speaks to German radio @DLF on the occasion of #ERC10yrs - Have a listen (in… https://t.co/2tErGhLDAu

@ERC_Research - 25 March 2017 14:47

Who won the EU #Foodscanner #HorizonPrize? Its aim is to help people make informed choices about their diet https://t.co/4Otiht3xtP #H2020

@EU_H2020 - 25 March 2017 12:48